VPTDF (VentriPoint Diagnostics) Ending Cash Position: $0.04 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VPTDF VentriPoint Diagnostics Ltd VPTDF
9 GF Score
Price $0.08
! 4 Warning Signs
View Full Analysis

What is VentriPoint Diagnostics Ending Cash Position?

VentriPoint Diagnostics VPTDF +4.57% 9 Ending Cash Position is $0.04 Mil as of Dec. 2025. GuruFocus rates VPTDF with a GF Score™ of 9/100. The stock has 4 warning signs investors should review.

VentriPoint Diagnostics's Ending Cash Position for the quarter that ended in Dec. 2025 was $0.04 Mil.

VentriPoint Diagnostics's quarterly Ending Cash Position declined from Jun. 2025 ($0.18 Mil) to Sep. 2025 ($0.05 Mil) and declined from Sep. 2025 ($0.05 Mil) to Dec. 2025 ($0.04 Mil).

VentriPoint Diagnostics's annual Ending Cash Position declined from Dec. 2023 ($0.97 Mil) to Dec. 2024 ($0.04 Mil) and declined from Dec. 2024 ($0.04 Mil) to Dec. 2025 ($0.04 Mil).

VentriPoint Diagnostics Ending Cash Position Related Terms

VentriPoint Diagnostics Ending Cash Position Historical Data

* Premium members only.

The historical data trend for VentriPoint Diagnostics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VentriPoint Diagnostics Ending Cash Position Chart

VentriPoint Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.24 3.82 0.97 0.04 0.04

VentriPoint Diagnostics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.25 0.18 0.05 0.04
VPTDF
9GF Score
VentriPoint Diagnostics Ltd VPTDF
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

VentriPoint Diagnostics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

VentriPoint Diagnostics's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.044+-0.004
=0.04

VentriPoint Diagnostics's Ending Cash Position for the quarter that ended in Dec. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.048+-0.008
=0.04

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.04 Mil mean?
VentriPoint Diagnostics (VPTDF) has a Ending Cash Position of $0.04 Mil as of Dec. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on VentriPoint Diagnostics and its competitors.
Is VentriPoint Diagnostics' Ending Cash Position too high?
VentriPoint Diagnostics' current Ending Cash Position is $0.04 Mil. Overall, VentriPoint Diagnostics has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does VentriPoint Diagnostics' Ending Cash Position compare to ABT and SYK?
VentriPoint Diagnostics' Ending Cash Position of $0.04 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on VentriPoint Diagnostics and its competitors. VentriPoint Diagnostics's current Ending Cash Position is $0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VentriPoint Diagnostics stock overvalued right now?
VentriPoint Diagnostics (VPTDF) has a current Ending Cash Position of $0.04 Mil. The current Ending Cash Position is $0.04 Mil. VentriPoint Diagnostics' overall GF Score™ is 9/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For VentriPoint Diagnostics (VPTDF), the current Ending Cash Position is $0.04 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

VentriPoint Diagnostics Business Description

Other Exchanges VPT:Canada
Address 18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.
9GF Score

Get the complete analysis for VPTDF

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price